SenzaGen AB (STO:SENZA)
Sweden · Delayed Price · Currency is SEK 5.32
+0.12 (2.31%)
Aug 13, 2026, 5:02 PM CET
SenzaGen AB Market Cap
SenzaGen AB has a market cap or net worth of 169.04 million as of August 13, 2026. Its market cap has decreased by -1.56% in one year.
Market Cap
169.04M
Enterprise Value
148.76M
Revenue
59.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.32
ChartMarket Cap Chart
Since September 21, 2017, SenzaGen AB's market cap has decreased from 669.46M to 169.04M, a decrease of -74.75%. That is a compound annual growth rate of -14.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 169.04M | -5.77% |
| Dec 30, 2025 | 179.38M | -11.88% |
| Dec 30, 2024 | 203.58M | 15.61% |
| Dec 29, 2023 | 176.09M | -39.28% |
| Dec 30, 2022 | 289.98M | 22.62% |
| Dec 30, 2021 | 236.48M | -15.48% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 157.39B |
| Getinge AB | 65.15B |
| Sectra AB | 52.21B |
| Medicover AB | 36.17B |
| Initiator Pharma | 177.29M |
| Ortivus AB | 175.47M |
| Abera Bioscience AB | 173.42M |
| Scandinavian Real Heart AB (Publ) | 170.81M |